168
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Prevalence of Positive QuantiFERON-TB Test among Sarcoid Uveitis Patients and its Clinical Implications in a Country Non-endemic for Tuberculosis

, MD, , MD, PhD, , MD, , MD, PhD, , MDORCID Icon & , MD, PhD
Pages 961-969 | Received 22 Nov 2021, Accepted 28 Apr 2022, Published online: 07 Jul 2022

References

  • Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS). the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS board of directors and by the ERS executive committee, February 1999. Am J Respir Crit Care Med. 1999;160:(2). 736–755. doi:10.1164/ajrccm.160.2.ats4-99.
  • Grunewald J, Grutters JC, Arkema EV, Saketkoo LA, Moller DR, Müller-Quernheim J. Sarcoidosis. Nat Rev Dis Primer. 2019;5(1):45. doi:10.1038/s41572-019-0096-x.
  • Bodaghi B, Touitou V, Fardeau C, Chapelon C, LeHoang P. Ocular sarcoidosis. Presse Médicale. 2012;41(6, Part 2):e349–e354. doi:10.1016/j.lpm.2012.04.004.
  • Sève P, Jamilloux Y, Tilikete C, Gerfaud-Valentin M, Kodjikian L, El Jammal T. Ocular sarcoidosis. Semin Respir Crit Care Med. 2020;41(5):673–688. doi:10.1055/s-0040-1710536.
  • Cordero-Coma M, Calleja S, Torres HE, et al. The value of an immune response to mycobacterium tuberculosis in patients with chronic posterior uveitides revisited: utility of the new IGRAs. Eye. 2010;24(1):36–43. doi:10.1038/eye.2009.51.
  • Standardization of Uveitis Nomenclature (SUN) Working Group. Classification criteria for tubercular uveitis. Am J Ophthalmol. 2021;228:142–151. doi:10.1016/j.ajo.2021.03.040.
  • Mochizuki M, Smith JR, Takase H, et al. Revised criteria of International Workshop on Ocular Sarcoidosis (IWOS) for the diagnosis of ocular sarcoidosis. Br J Ophthalmol. 2019;103(10):1418–1422. doi:10.1136/bjophthalmol-2018-313356.
  • Jabs DA, Nussenblatt RB, Rosenbaum JT, Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol. 2005;140(3):509–516. doi:10.1016/j.ajo.2005.03.057.
  • Jones NP, Tsierkezou L, Patton N. Lymphopenia as a predictor of sarcoidosis in patients with uveitis. Br J Ophthalmol. 2016;100(10):1393–1396. doi:10.1136/bjophthalmol-2015-307455.
  • Scadding JG. Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years’ observation. Br Med J. 1961;2(5261):1165–1172. doi:10.1136/bmj.2.5261.1165.
  • Clement DS, Postma G, Rothova A, Grutters JC, Prokop M, de Jong PA. Intraocular sarcoidosis: association of clinical characteristics of uveitis with positive chest high-resolution computed tomography findings. Br J Ophthalmol. 2010;94(2):219–222. doi:10.1136/bjo.2009.161588.
  • Skoura E, Zumla A, Bomanji J. Imaging in tuberculosis. Int J Infect Dis IJID Off Publ Int Soc Infect Dis. 2015;32:87–93. doi:10.1016/j.ijid.2014.12.007.
  • Groen-Hakan F, van Laar JAM, Bakker M, van Hagen PM, Hardjosantoso H, Rothova A. Prevalence of positive quantiFERON-TB gold in-tube test in uveitis and its clinical implications in a country nonendemic for tuberculosis. Am J Ophthalmol. 2020;211:151–158. doi:10.1016/j.ajo.2019.11.009.
  • Rahmi A, Deshayes E, Maucort-Boulch D, et al. Intraocular sarcoidosis: association of clinical characteristics of uveitis with findings from 18F-labelled fluorodeoxyglucose positron emission tomography. Br J Ophthalmol. 2012;96(1):99–103. doi:10.1136/bjo.2010.194514.
  • Quartier-Dit-Maire P, Saadoun D, Belot A, et al. Protocole National de Diagnostic et de soins sur les Uvéites Chroniques Non Infectieuses de l’enfant et de l’adulte. Published online 2020:85.
  • Abad S, Meyssonier V, Allali J, et al. Association of peripheral multifocal choroiditis with sarcoidosis: a study of thirty-seven patients. Arthritis Care Res. 2004;51(6):974–982. doi:10.1002/art.20839.
  • CLSI. Laboratory Detection and Identification of Mycobacteria. 2nd CLSI guidelines M48. Wayne, PA: Clinical and Laboratory Standards Institute; 2018.
  • Amara A, Ben Salah E, Guihot A, et al. Observational study of quantiferon® management for ocular tuberculosis diagnosis: analysis of 244 consecutive tests. Rev Med Interne. 2021;42(3):162–169. doi:10.1016/j.revmed.2020.09.005.
  • Jakob E, Max R, Zimmermann S, et al. Three years of experience with quantiferon-TB gold testing in patients with uveitis. Ocul Immunol Inflamm. 2014;22(6):478–484. doi:10.3109/09273948.2013.866255.
  • Yakin M, Kesav N, Cheng SK, Caplash S, Gangaputra S, Sen HN. The association between quantiFERON-TB gold test and clinical manifestations of uveitis in the United States. Am J Ophthalmol. 2021;230:181–187. doi:10.1016/j.ajo.2021.04.024.
  • Kempisty A, Białas-Chromiec B, Borkowska D, Kuś J. Interferon gamma release assays based on M. tuberculosis-specific antigens in sarcoidosis patients. Pneumonol Alergol Pol. 2015;83(2):126–134. doi:10.5603/PiAP.2015.0020.
  • Gupta D, Kumar S, Aggarwal AN, Verma I, Agarwal R. Interferon gamma release assay (quantiferon-TB gold in tube) in patients of sarcoidosis from a population with high prevalence of tuberculosis infection. Sarcoidosis Vasc Diffuse Lung Dis Off J WASOG. 2011;28:95–101.
  • Testi I, Tognon MS, Gupta V. Diagnostic challenges in granulomatous uveitis: tuberculosis or sarcoidosis? Ocul Immunol Inflamm. 2019;27(7):1049–1051. doi:10.1080/09273948.2018.1491997.
  • Drake WP, Pei Z, Pride DT, Collins RD, Cover TL, Blaser MJ. Molecular analysis of sarcoidosis tissues for mycobacterium species DNA. Emerg Infect Dis. 2002;8(11):1334–1341. doi:10.3201/eid0811.020318.
  • Beijer E, Seldenrijk K, Eishi Y, et al. Presence of propionibacterium acnes in granulomas associates with a chronic disease course in Dutch sarcoidosis patients. ERJ Open Res. 2021;7(1):00486–02020. doi:10.1183/23120541.00486-2020.
  • Eishi Y, Suga M, Ishige I, et al. Quantitative analysis of mycobacterial and propionibacterial DNA in lymph nodes of Japanese and European patients with sarcoidosis. J Clin Microbiol. 2002;40(1):198–204. doi:10.1128/JCM.40.1.198-204.2002.
  • Ishige I, Usui Y, Takemura T, Eishi Y. Quantitative PCR of mycobacterial and propionibacterial DNA in lymph nodes of Japanese patients with sarcoidosis. Lancet Lond Engl. 1999;354(9173):120–123. doi:10.1016/S0140-6736(98)12310-3.
  • Goto H, Usui Y, Umazume A, Uchida K, Eishi Y. Propionibacterium acnes as a possible pathogen of granuloma in patients with ocular sarcoidosis. Br J Ophthalmol. 2017;101(11):1510–1513. doi:10.1136/bjophthalmol-2016-309248.
  • Nagata K, Eishi Y, Uchida K, et al. Immunohistochemical detection of propionibacterium acnes in the retinal granulomas in patients with ocular sarcoidosis. Sci Rep. 2017;7(1):15226. doi:10.1038/s41598-017-15710-0.
  • Saboor SA, Johnson NM, McFadden J, Johnson NM. Detection of mycobacterial DNA in sarcoidosis and tuberculosis with polymerase chain reaction. Lancet Lond Engl. 1992;339(8800):1012–1015. doi:10.1016/0140-6736(92)90535-b.
  • Gupta D, Agarwal R, Aggarwal AN, Jindal SK. Molecular evidence for the role of mycobacteria in sarcoidosis: a meta-analysis. Eur Respir J. 2007;30(3):508–516. doi:10.1183/09031936.00002607.
  • Song Z, Marzilli L, Greenlee BM, et al. Mycobacterial catalase–peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis. J Exp Med. 2005;201(5):755–767. doi:10.1084/jem.20040429.
  • Rossman MD, Thompson B, Frederick M, et al. HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites. Am J Hum Genet. 2003;73(4):720–735. doi:10.1086/378097.
  • Tong X, Chen L, Liu S, et al. Polymorphisms in HLA-DRB1 gene and the risk of tuberculosis: a meta-analysis of 31 studies. Lung. 2015;193(2):309–318. doi:10.1007/s00408-015-9692-z.
  • Oswald-Richter K, Sato H, Hajizadeh R, et al. Mycobacterial ESAT-6 and katG are recognized by sarcoidosis CD4+ T cells when presented by the American sarcoidosis susceptibility allele, DRB1*1101. J Clin Immunol. 2010;30(1):157–166. doi:10.1007/s10875-009-9311-y.
  • Koth LL, Solberg OD, Peng JC, Bhakta NR, Nguyen CP, Woodruff PG. Sarcoidosis blood transcriptome reflects lung inflammation and overlaps with tuberculosis. Am J Respir Crit Care Med. 2011;184(10):1153–1163. doi:10.1164/rccm.201106-1143OC.
  • Agrawal R, Kee AR, Ang L, et al. Tuberculosis or sarcoidosis: opposite ends of the same disease spectrum? Tuberc Edinb Scotl. 2016;98:21–26. doi:10.1016/j.tube.2016.01.003
  • Accorinti M, Okada AA, Smith JR, Gilardi M. Epidemiology of macular edema in uveitis. Ocul Immunol Inflamm. 2019;27(2):169–180. doi:10.1080/09273948.2019.1576910.
  • Gupta A, Sharma A, Bansal R, Sharma K. Classification of intraocular tuberculosis. Ocul Immunol Inflamm. 2015;23(1):7–13. doi:10.3109/09273948.2014.967358.
  • Gupta V, Gupta A, Rao NA. Intraocular tuberculosis–an update. Surv Ophthalmol. 2007;52(6):561–587. doi:10.1016/j.survophthal.2007.08.015.
  • La Distia Nora R, van Velthoven MEJ, Ten Dam-van Loon NH, et al. Clinical manifestations of patients with intraocular inflammation and positive quantiferon-TB gold in-tube test in a country nonendemic for tuberculosis. Am J Ophthalmol. 2014;157(4):754–761. doi:10.1016/j.ajo.2013.11.013.
  • Herbort CP, Rao NA, Mochizuki M, Members Ofscientific Commi T, members of Scientific Committee of First International Workshop on Ocular Sarcoidosis. International criteria for the diagnosis of ocular sarcoidosis: results of the first International Workshop On Ocular Sarcoidosis (IWOS). Ocul Immunol Inflamm. 2009;17(3):160–169. doi:10.1080/09273940902818861.
  • Acharya NR, Browne EN, Rao N, Mochizuki M. Distinguishing features of ocular sarcoidosis in an international cohort of uveitis patients. Ophthalmology. 2018;125(1):119–126. doi:10.1016/j.ophtha.2017.07.006.
  • Handa-Miyauchi M, Takase H, Tanaka M, Akiyama M, Ohno-Matsui K, Mochizuki M. A validation study of the revised diagnostic criteria from the international workshop on ocular sarcoidosis at a single institute in Japan. Ocul Immunol Inflamm. 2020 May 29:1–6. doi:10.1080/09273948.2020.1758159. Published online.
  • Standardization of Uveitis Nomenclature (SUN) Working Group. Classification criteria for sarcoidosis-associated uveitis. Am J Ophthalmol. 2021;228:220–230. doi:10.1016/j.ajo.2021.03.047.
  • Agrawal R, Agarwal A, Jabs DA, et al. Standardization of nomenclature for ocular tuberculosis - results of Collaborative Ocular Tuberculosis Study (COTS) workshop. Ocul Immunol Inflamm. December 10, 2019;1–11. Published online. doi:10.1080/09273948.2019.1653933.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.